Sundaram Sridhar, Patil Gaurav Kumar, Jain Aadish Kumar, Dalal Ankit, Patil Prachi, Mehta Shaesta, Maydeo Amit
Department of Digestive Diseases and Clinical Nutrition, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, 400 012, India.
Institute of Gastrosciences, Sir H N Reliance Foundation Hospital, Mumbai, 400 004, India.
Indian J Gastroenterol. 2025 Feb;44(1):80-87. doi: 10.1007/s12664-024-01661-8. Epub 2024 Sep 7.
Underwater endoscopic mucosal resection (uEMR) represents an alternative to conventional EMR for resection of sessile colorectal polyps. We aimed at assessing the efficacy and safety of uEMR for sessile colorectal polyps.
A retrospective analysis of endoscopy database was done for patients who underwent uEMR for sessile colorectal polyps more than 10 mm in size without any features of sub-mucosal invasion from two tertiary care centres in western India between January 2021 and June 2023. Exclusion criteria were other modes of endoscopic resection. Primary outcome was rate of en bloc resection. Secondary outcomes were complete resection rate, adverse events and recurrence rate.
During the study period, 159 patients with 261 lesions met the study inclusion. Mean lesion size was 1.935 ± 0.71 cm with most lesion located in the rectum (75, 28.73%) followed by sigmoid colon (69, 26.43%). Most lesions had a Paris 0-Is morphology (192, 73.56%). Japan NBI Expert Team (JNET) IIa pattern was seen on narrow band imaging (NBI) in 221 (84.67%) lesions. Complete resection was achieved in 98.46% lesions (257/261). En bloc resection was achieved in 91.82% (236/257) lesions. Complications were seen in 6.8%, all of which were managed endoscopically. Recurrence was seen in 3.1% of polyps on follow-up.
uEMR is a safe and efficacious technique for endoscopic resection for sessile colorectal polyps with high rates of en bloc resection for polyps more than 10 mm size.
水下内镜黏膜切除术(uEMR)是切除无蒂结直肠息肉的一种替代传统EMR的方法。我们旨在评估uEMR治疗无蒂结直肠息肉的疗效和安全性。
对2021年1月至2023年6月期间在印度西部两个三级医疗中心接受uEMR治疗的大小超过10mm且无任何黏膜下浸润特征的无蒂结直肠息肉患者的内镜数据库进行回顾性分析。排除标准为其他内镜切除方式。主要结局是整块切除率。次要结局是完全切除率、不良事件和复发率。
在研究期间,159例患者的261个病变符合研究纳入标准。病变平均大小为1.935±0.71cm,大多数病变位于直肠(75个,28.73%),其次是乙状结肠(69个,26.43%)。大多数病变具有巴黎0-Is形态(192个,73.56%)。221个(84.67%)病变在窄带成像(NBI)下表现为日本NBI专家团队(JNET)IIa型。98.46%的病变(257/261)实现了完全切除。91.82%(236/257)的病变实现了整块切除。6.8%的患者出现并发症,均通过内镜处理。随访中息肉复发率为3.1%。
uEMR是一种安全有效的内镜切除技术,对于大小超过10mm的无蒂结直肠息肉具有较高的整块切除率。